Hematological Malignancies

Radioimmunotherapy and Radiotherapy and immunotherapy combinations

Tim Illidge Professor of Targeted Therapy and Oncology BSc PhD DRCOG FRCP FRCR FRCPath Institute of Cancer Sciences Manchester Academic Health Sciences Centre

Manchester University The Christie Hospital Manchester , UK

Made with